Received Apr 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EL9263 | UN |
Hospitalization related to COVID 19 following completion of primary vaccine series
? Health care maintenance 11/02/2022 AAA: Negative screening 2018 Colorectal cancer: 23 polyps, most tubula adenomas, 5/2018 ? Bladder outlet obstruction 10/28/2022 ? BPH (benign prostatic hyperplasia) 10/28/2022 ? Urinary symptom or sign 10/28/2022 ? Anemia due to blood loss 10/28/2022 ? Orthostatic hypotension 10/28/2022 ? Hypertension 10/28/2022 ? Hyponatremia 10/28/2022 ? Obesity (BMI 30-39.9) 10/28/2022 ? Peripheral vascular disease (HCC) 10/28/2022 Abnormal ABI 11/12 suggesting distal L LE arterial disease, asymptomatic ? Prediabetes 10/28/2022 ? Urinary retention 10/28/2022 ? Chronic lumbar pain 10/28/2022 ? Impaired mobility 10/28/2022 ? Muscle weakness 10/28/2022 ? Permanent atrial fibrillation (HCC) 10/28/2022 Incidentally discovered. Status post cardioversion 05/21/2015. TTE unremarkable but for LVH. On warfarin. Currently rate controlled with metoprolol. ? Warfarin anticoagulation 10/28/2022 ? Complaints of memory disturbance 10/28/2022 B12/TSH normal 2018 ? Neuropathy 10/28/2022 On EMG 2020; SPEP, B12 TSH normal. Not diabetic. ? Primary localized osteoarthritis of right knee 10/28/2022 ? Gait disturbance 10/28/2022 ? Right knee pain 10/28/2022 ? Venous stasis 10/28/2022 ? Bunion, left 10/28/2022 ? Balance disorder 10/28/2022 ? Chronic reflux esophagitis 10/28/2022 EGD 2006 and 2007. Erosive esophagitis. No Barrets.
? Health care maintenance 11/02/2022 AAA: Negative screening 2018 Colorectal cancer: 23 polyps, most tubula adenomas, 5/2018 ? Bladder outlet obstruction 10/28/2022 ? BPH (benign prostatic hyperplasia) 10/28/2022 ? Urinary symptom or sign 10/28/2022 ? Anemia due to blood loss 10/28/2022 ? Orthostatic hypotension 10/28/2022 ? Hypertension 10/28/2022 ? Hyponatremia 10/28/2022 ? Obesity (BMI 30-39.9) 10/28/2022 ? Peripheral vascular disease (HCC) 10/28/2022 Abnormal ABI 11/12 suggesting distal L LE arterial disease, asymptomatic ? Prediabetes 10/28/2022 ? Urinary retention 10/28/2022 ? Chronic lumbar pain 10/28/2022 ? Impaired mobility 10/28/2022 ? Muscle weakness 10/28/2022 ? Permanent atrial fibrillation (HCC) 10/28/2022 Incidentally discovered. Status post cardioversion 05/21/2015. TTE unremarkable but for LVH. On warfarin. Currently rate controlled with metoprolol. ? Warfarin anticoagulation 10/28/2022 ? Complaints of memory disturbance 10/28/2022 B12/TSH normal 2018 ? Neuropathy 10/28/2022 On EMG 2020; SPEP, B12 TSH normal. Not diabetic. ? Primary localized osteoarthritis of right knee 10/28/2022 ? Gait disturbance 10/28/2022 ? Right knee pain 10/28/2022 ? Venous stasis 10/28/2022 ? Bunion, left 10/28/2022 ? Balance disorder 10/28/2022 ? Chronic reflux esophagitis 10/28/2022 EGD 2006 and 2007. Erosive esophagitis. No Barrets.
Unknown
NSAIDS, Sulfa
Covid positive test date 3/12/2025